Carla Soranzo

437 total citations
21 papers, 363 citations indexed

About

Carla Soranzo is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Carla Soranzo has authored 21 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Genetics. Recurrent topics in Carla Soranzo's work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer Research and Treatments (3 papers). Carla Soranzo is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (6 papers) and Cancer Research and Treatments (3 papers). Carla Soranzo collaborates with scholars based in Italy. Carla Soranzo's co-authors include Graziella Pratesi, Antonella Ingrosso, Anna Maria Casazza, Federico Arcamone, Franco Zunino, Giovanni Capranico, A. Di Marco, Luigi Rossi Bernardi, Roberto Foroni and Monica Tortoreto and has published in prestigious journals such as British Journal of Cancer, Cellular and Molecular Life Sciences and Cancer Letters.

In The Last Decade

Carla Soranzo

21 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Soranzo Italy 11 164 163 81 62 48 21 363
Shuichi Fujimoto Japan 13 226 1.4× 186 1.1× 59 0.7× 35 0.6× 15 0.3× 46 465
Lisa Polin United States 12 234 1.4× 111 0.7× 100 1.2× 48 0.8× 6 0.1× 19 392
Hironori Kawabata Japan 9 285 1.7× 284 1.7× 22 0.3× 24 0.4× 19 0.4× 9 456
Pamela Roper United States 7 145 0.9× 100 0.6× 21 0.3× 14 0.2× 25 0.5× 11 349
Ahmed S.A. Mady United States 9 341 2.1× 114 0.7× 81 1.0× 46 0.7× 10 0.2× 13 444
Sueo Mukumoto Japan 8 310 1.9× 120 0.7× 61 0.8× 31 0.5× 6 0.1× 9 495
Abdul M. Deffie Canada 9 539 3.3× 491 3.0× 57 0.7× 21 0.3× 22 0.5× 10 726
Janice Mayes United States 10 496 3.0× 301 1.8× 77 1.0× 24 0.4× 11 0.2× 17 549
Paul Vichi United States 9 478 2.9× 176 1.1× 24 0.3× 9 0.1× 29 0.6× 10 618
Naoki Teno Japan 15 218 1.3× 156 1.0× 133 1.6× 19 0.3× 19 0.4× 52 561

Countries citing papers authored by Carla Soranzo

Since Specialization
Citations

This map shows the geographic impact of Carla Soranzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Soranzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Soranzo more than expected).

Fields of papers citing papers by Carla Soranzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Soranzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Soranzo. The network helps show where Carla Soranzo may publish in the future.

Co-authorship network of co-authors of Carla Soranzo

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Soranzo. A scholar is included among the top collaborators of Carla Soranzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Soranzo. Carla Soranzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perego, Paola, A. Boiardi, Nives Carenini, et al.. (1994). Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs. Journal of Cancer Research and Clinical Oncology. 120(10). 585–592. 24 indexed citations
3.
Soranzo, Carla, Paola Perego, & Franco Zunino. (1990). Effect of tumor necrosis factor on human tumor cell lines sensitive and resistant to cytotoxic drugs, and its interaction with chemotherapeutic agents. Anti-Cancer Drugs. 1(2). 157–164. 9 indexed citations
4.
Soranzo, Carla, Graziella Pratesi, & Franco Zunino. (1990). Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systems. Anti-Cancer Drugs. 1(1). 23–28. 4 indexed citations
5.
Soranzo, Carla, et al.. (1989). Changes in the three-dimensional organization of LoVo cells associated with resistance to doxorubicin. Cancer Letters. 48(1). 37–41. 3 indexed citations
6.
Demicheli, Romano, Roberto Foroni, Antonella Ingrosso, et al.. (1989). An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data.. PubMed. 49(23). 6543–6. 55 indexed citations
7.
Soranzo, Carla, Antonella Ingrosso, Graziella Pratesi, et al.. (1989). Malignant transformation of host cells by a human small cell lung cancer xenografted into nude mice.. PubMed. 9(2). 361–6. 6 indexed citations
8.
Soranzo, Carla, Gabriella Della Torre, & Antonella Ingrosso. (1986). Formation, Growth and Morphology of Multicellular Tumor Spheroids from a Human Colon Carcinoma Cell Line (LoVo). Tumori Journal. 72(5). 459–467. 16 indexed citations
9.
Capranico, Giovanni, Carla Soranzo, & Franco Zunino. (1986). Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.. PubMed. 46(11). 5499–503. 32 indexed citations
10.
Capranico, Giovanni, Nora Babudri, Lucilla Dolzani, et al.. (1986). Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cells. Chemico-Biological Interactions. 57(2). 189–201. 9 indexed citations
11.
Cassinelli, Giuseppe, Salvatore Forenza, Federico Arcamone, et al.. (1980). New anthracycline glycosides from Micromonospora. II. Isolation, characterization and biological properties.. The Journal of Antibiotics. 33(12). 1468–1473. 27 indexed citations
12.
Grein, A., Paolo Masi, Luigi Rossi Bernardi, et al.. (1978). Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.. The Journal of Antibiotics. 31(3). 178–184. 26 indexed citations
13.
Arcamone, Federico, Luigi Rossi Bernardi, A. Di Marco, et al.. (1978). Synthesis and antitumour activity of new daunorubicin and adriamycin analogues. Cellular and Molecular Life Sciences. 34(10). 1255–1257. 59 indexed citations
14.
Marco, Aurelio Di, Anna Maria Casazza, Carla Soranzo, & Graziella Pratesi. (1978). Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin. Cancer Chemotherapy and Pharmacology. 1(4). 249–254. 9 indexed citations
15.
Casazza, Anna Maria, et al.. (1977). Effect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth. British Journal of Cancer. 35(2). 190–198. 1 indexed citations
16.
Arcamone, Federico, Sergio Penco, Aristide Vigevani, et al.. (1975). ChemInform Abstract: SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE. Chemischer Informationsdienst. 6(40). 28 indexed citations
17.
Arcamone, Federico, G. FRANCESCHI, A. Minghetti, et al.. (1974). ChemInform Abstract: SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME 14‐O‐ACYL DERIVATIVES OF ADRIAMYCIN. Chemischer Informationsdienst. 5(33). 1 indexed citations
18.
A, Di Marco, Teresa Dasdia, Fernando C. Giuliani, et al.. (1974). Cytotoxic, antiviral, and antitumor activity of some derivatives of daunomycin (NSC-82151).. PubMed. 57(3). 269–74. 12 indexed citations
19.
Giuliani, Fernando C., Carla Soranzo, Anna Maria Casazza, & Aurelio Di Marco. (1973). Oncogenicity of Immune Lymphoid Cells from MSV-M Regressors. Tumori Journal. 59(4). 269–275. 2 indexed citations
20.
Prakash, Chandra, A. Di Marco, Franco Zunino, et al.. (1972). Influence of some antitumor antibiotics on viral neoplasia. Die Naturwissenschaften. 59(10). 448–455. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026